Cargando…
The Impact of Cardiac Comorbidity Sequence at Baseline and Mortality Risk in Type 2 Diabetes Mellitus: A Retrospective Population-Based Cohort Study
Introduction: The presence of multiple comorbidities increases the risk of all-cause mortality, but the effects of the comorbidity sequence before the baseline date on mortality remain unexplored. This study investigated the relationship between coronary heart disease (CHD), atrial fibrillation (AF)...
Autores principales: | Lee, Sharen, Huang, Helen, Lee, Teddy Tai Loy, Chung, Cheuk To, Chou, Oscar Hou In, Leung, Keith Sai Kit, Wai, Abraham Ka Chung, Wong, Wing Tak, Liu, Tong, Chang, Carlin, Tse, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781363/ https://www.ncbi.nlm.nih.gov/pubmed/36556321 http://dx.doi.org/10.3390/life12121956 |
Ejemplares similares
-
Predictive value of neutrophil‐to‐lymphocyte ratio for atrial fibrillation and stroke in type 2 diabetes mellitus: The Hong Kong Diabetes Study
por: Chang, Carlin, et al.
Publicado: (2022) -
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis
por: Mui, Jonathan V., et al.
Publicado: (2021) -
Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study
por: Chan, Raymond Ngai Chiu, et al.
Publicado: (2022) -
Low rates of liver injury in edoxaban users: Evidence from a territory‐wide observational cohort study
por: Zhou, Jiandong, et al.
Publicado: (2021) -
Sodium‐glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new‐onset overall cancer in Type 2 diabetes mellitus: A population‐based study
por: Chung, Cheuk To, et al.
Publicado: (2023)